Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 0% |
 |
Gilead SciencesGILD |
59 1.7% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Nov 2024 | 70 | |
| Oct 2024 | 67 | |
| Sep 2024 | 64 | |
| Aug 2024 | 58 |
How do employees feel about the future at Alnylam Pharmaceuticals?
The Business Outlook at Alnylam Pharmaceuticals is positive according to its employees. The average outlook rating 70 (out of 100) is high.
Analyzing Business Outlook, how is Alnylam Pharmaceuticals performing compared to its industry peers?
Alnylam Pharmaceuticals overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 70th percentile.
How has the business outlook at Alnylam Pharmaceuticals changed over the last couple of months
In recent months, Alnylam Pharmaceuticals' employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Alnylam Pharmaceuticals?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Alnylam Pharmaceuticals.
